Preemie
Financiado
Personalised nutrition of low birth weight infants
Each year 500,000 preterm babies are born in Europe out of 15-million worldwide. They often have poor health, with a severe lifetime impact on their quality of life and that of their families. Pre-term birth is a leading cause of...
Each year 500,000 preterm babies are born in Europe out of 15-million worldwide. They often have poor health, with a severe lifetime impact on their quality of life and that of their families. Pre-term birth is a leading cause of lifelong disabilities with high societal economic costs. Inadequate nutrition is the major reason for preterm infants’ ill health. To grow as they would in utero, preterm infants need more nutrition than is provided by their mother’s milk, so the milk needs to be fortified to avoid undernourishment. However, the fortification typically done in Neonatal Intensive Care Units (NICUs) does not take into account the individual differences in the human milk’s composition and the infant’s nutritional needs, which vary with age and weight.
To address this issue, Tellspec has developed Preemie, the first rapid, portable, affordable, and easy-to-use milk testing system calibrated with human milk, that automatically calculates the fortification needed, to reduce the workload and human errors. Preemie also uses blockchain technology to trace the origin and confirm the authenticity of the donor’s milk. An inexpensive portable and rapid analyser such as Preemie would disrupt the existing market by allowing NICUs and milk banks to scan all donor milk and automatically suggest fortification to be done based on each infant's individual needs, resulting in optimal health.
In this project Tellspec will commercialise Preemie, by tailoring the software to the market and validate it in collaboration with a European hospital and a milk bank, by obtaining the medical certification needed to go to market, and by implementing advertising, sales promotions and marketing activities.
The funds raised will enable Tellspec to enlarge its customer base, expand the current team of people, set up high-volume distribution capacity in Europe, and consolidate the business strategy to pave the way for future VC investments.
ver más
Duración del proyecto: 29 meses
Fecha Inicio: 2019-11-09
Fecha Fin: 2022-04-30
Fecha Fin: 2022-04-30
Línea de financiación: concedida
El organismo H2020 notifico la concesión del proyecto el día 2022-04-30
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
EIC-SMEInst-2018-2020:
SME instrument
Cerrada
hace 6 años
Presupuesto
El presupuesto total del proyecto asciende a
2M€
Líder del proyecto
TELLSPEC LTD
No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico
TRL
4-5
Perfil tecnológico
TRL
4-5
403.18K€ |
Participante